Western Blotting Market To Gain Demand Quickly Due To Growing R&D Activities Made By Pharmaceutical & Biotechnology Companies Till 2025: Grand View Research, Inc.
The
global western blotting market is anticipated to reach a
value of USD 958.4 millionby 2025, according to a new report by Grand View
Research, Inc. Rising number of cases with HIV are increasingly contributing
towards the growth of western blotting market. This kind of testing is highly
effective in detecting HIV among people. According to UNAIDS, nearly 36.7
million people were living with HIV throughout the world in 2015. Such high
prevalence of HIV is expected to accelerate the demand for products used in
western blotting. Lyme diseases also require western blotting to detect Borrelia
burgdorferi (Bb), which causes such diseases. Other diseases which
require western blot for detection of specific proteins include mad cow
disease, hepatitis, and feline immunodeficiency.
Moreover,
significant investments in R&D activities made by pharmaceutical and
biotechnology companies are expected to foster growth of western blotting
market. According to a news journal, biotech companies spent USD 40.1 billion
in 2015 on R&D activities, which was a 16% rise from their 2014
investments. Hence, with rising number of R&D activities, there is an
expected rise in the demand for western blotting tests in the near future.
U.S.
western blotting market, by product, 2014 - 2025 (USD Million)
Browse full
research report on Western Blotting Market: http://www.grandviewresearch.com/industry-analysis/western-blotting-market
Further
key findings from the report suggest:
- In 2016, consumables segment held the largest
market share and is also expected to exhibit fastest growth over the
forecast period owing to rising diagnostic and research-based activities
requiring western blotting
- Amongst the application segment, biomedical
& biochemical research contributed towards the largest revenue share
in 2016 due to increasing government spending in proteomics research
- The disease diagnostics segment is anticipated
to witness highest CAGR over the forecast period due to rising
epidemiology of HIV, Lyme, and other related diseases
- Amongst the end-use segment, such as academic
& research institutes dominated the market in 2016 owing to growing
number of research activities conducted by educational institutions
supported by government funding
- The pharmaceutical and biotechnology companies
are expected to grow at a significant CAGR over the forecast period due to
increasing R&D spending by such companies
- Some of the key players are Bio-Rad
Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche
Ltd., GE Healthcare, LI-COR Biosciences, Bio-Techne Corporation, PerkinElmer,
Inc., and Merck KGaA.
Browse more
reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the western blotting market on the
basis of product, application, end-use and region:
Western
Blotting Product Outlook (Revenue, USD Million; 2014 - 2025)
- Instruments
- Gel
Electrophoresis Instruments
- Blotting
Systems
- Semi-Dry
Blotting Instruments
- Wet
Blotting Instruments
- Imagers
- Chemiluminescent
Imagers
- Fluorescent
Imagers
- Others
- Consumables
- Reagents
- Kits
- Others
Western
Blotting Application Outlook (Revenue, USD Million; 2014 - 2025)
- Biomedical
& Biochemical Research
- Disease
Diagnostics
- Agriculture
- Others
Western
Blotting End-Use Outlook (Revenue, USD Million; 2014 - 2025)
- Academic
& Research Institutes
- Pharmaceutical
& Biotechnology Companies
- Diagnostic
Centers
- Others
Western
Blotting Regional Outlook (Revenue, USD Million; 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-western-blotting-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment